Burns et al. described that 84% of the MBP-reactive T cells are memory T cells in peripheral blood [136] but, according to Chou et al., only 37% of T cells isolated from patients with MS are MBP- or PLP-reactive in LCR [137]. This evidence concerns the gene MBP and myeloid sarcoma.